title: Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance hemofiltration: a case of central hypothyroidism.
abstract: Thyrotropin (TSH) secretion was evaluated in a group of patients with chronic renal failure (CRF) undergoing regular maintenance hemofiltration and in normal controls. The study group included 68 patients (39 males and 29 females, age range 39-73 years, mean: 53 years). In all patients blood was drawn at 08:30-09:00 h; in 20 patients the nocturnal (24:00-02:00 h) serum TSH peak was also evaluated; 12 patients underwent stimulation test with synthetic TSH-releasing hormone (TRH). TSH was measured by an ultrasensitive immunoradiometric assay. CRF patients showed a significant decrease in serum total and free thyroxine and triiodothyronine concentrations, which in a substantial proportion of subjects were below the lower normal limit. Serum reverse triiodothyronine and thyroxine-binding globulin values did not differ in the two groups. Despite this trend of thyroid hormones to decrease, no patient had supranormal TSH values as in primary hypothyroidism. While the mean morning TSH concentrations of CRF patients did not differ from those of controls, the mean nocturnal values were significantly reduced in CRF (1.0 +/- 0.2 vs 3.2 +/- 0.4 mU/l, p less than 0.0005) and the nocturnal serum TSH surge was not observed in 18 of the 20 patients (90%) in whom it was evaluated. The mean serum TSH peak value after TSH-releasing hormone (TRH) administration was also reduced in CRF patients, and the TSH response to TRH was blunted in 3 out of 12 patients (25%). The results of this study demonstrate a major impairment of TSH secretion in CRF, which baseline TSH measurements in the morning and the evaluation of the TSH response to TRH may not reveal.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Istituto di Endocrinologia, University of Pisa, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Bartalena
authors.forename: A
authors.initials: A
authors.lastname: Pacchiarotti
authors.forename: R
authors.initials: R
authors.lastname: Palla
authors.forename: L
authors.initials: L
authors.lastname: Antonangeli
authors.forename: C
authors.initials: C
authors.lastname: Mammoli
authors.forename: F
authors.initials: F
authors.lastname: Monzani
authors.forename: F
authors.initials: F
authors.lastname: De Negri
authors.forename: V
authors.initials: V
authors.lastname: Panichi
authors.forename: E
authors.initials: E
authors.lastname: Martino
authors.forename: L
authors.initials: L
authors.lastname: Baschieri
mesh_terms: D000328:Adult; D000368:Aged; D002940:Circadian Rhythm; D005260:Female; D006440:Hemofiltration; D006801:Humans; D007037:Hypothyroidism / Q000150:complications*; D015592:Immunoradiometric Assay; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine